Literature DB >> 30001856

Interpretation of the switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10 in Belgium.

Patricia Izurieta1, Thomas Breuer2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30001856     DOI: 10.1016/S1473-3099(18)30410-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium.

Authors:  Matt D Wasserman; Heather L Sings; Michele R Wilson; Maarten J Postma; Marie-Claude Breton; Cheryl McDade; Raymond A Farkouh
Journal:  Infect Dis Ther       Date:  2018-11-20

Review 2.  Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia.

Authors:  Auliya A Suwantika; Neily Zakiyah; Arif S W Kusuma; Rizky Abdulah; Maarten J Postma
Journal:  Vaccines (Basel)       Date:  2020-05-18

3.  Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy.

Authors:  Filippo Ansaldi; Sarah Pugh; Daniela Amicizia; Roberto Di Virgilio; Cecilia Trucchi; Andrea Orsi; Alessandro Zollo; Giancarlo Icardi
Journal:  Pathogens       Date:  2020-01-22

4.  Invasive Pneumococcal Disease in Tuscany Region, Italy, 2016-2017: Integrating Multiple Data Sources to Investigate Underreporting.

Authors:  Filippo Quattrone; Gabriele Donzelli; Sara D'Arienzo; Marco Fornili; Francesco Innocenti; Silvia Forni; Laura Baglietto; Lara Tavoschi; Pier Luigi Lopalco
Journal:  Int J Environ Res Public Health       Date:  2020-10-19       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.